Commercialisation of disease management

PRRT plus holmium-166-SIRT (HEPAR PLuS) versus PRRT-only in patients with metastatic neuroendocrine tumors: A propensity-score matched analysis.

Journal of neuroendocrinology·2025

Positive Development and Changes in Self-Rated Health Among Young Sexual Minority Males: The P18 Cohort Study.

Behavioral medicine (Washington, D.C.)·2019

A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning.

Journal of neurology·2017

HPLC & NMR-based forced degradation studies of ifosfamide: The potential of NMR in stability studies.

Annales pharmaceutiques francaises·2015

Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis.

CPT: pharmacometrics & systems pharmacology·2015

Retrospective analysis of second-line chemotherapy outcomes with paclitaxel or docetaxel in correlation with STMN1 polymorphism in advanced non-small cell lung cancer patients.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2015

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

How does on-demand delivery impact the accessibility and equity of community pharmacies? Perspective from groups with heterogeneous geographic-digital barriers.

Frontiers in public health·2026

Sustaining Health Promotion in Australian Supermarkets: Qualitative Perspectives From the Reach for the Stars Programme.

Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals·2026

A descriptive analysis for the markets for counterfeit products.

Proceedings of the National Academy of Sciences of the United States of America·2026

Do not smile when acquiring consumer selfies for multi-attribute skin profiling and baseline deep learning evaluation.

Scientific reports·2026

E-cigarette concept flavors in the United States: An analysis of product packages from online stores.

Preventive medicine reports·2026

Misalignment between ultra-processed status and 'better for you' claims on premix alcohol products.

The International journal on drug policy·2026

Related Experiment Videos

Commercialisation of disease management

Related Concept Videos

PRRT plus holmium-166-SIRT (HEPAR PLuS) versus PRRT-only in patients with metastatic neuroendocrine tumors: A propensity-score matched analysis.

Positive Development and Changes in Self-Rated Health Among Young Sexual Minority Males: The P18 Cohort Study.

A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning.

HPLC & NMR-based forced degradation studies of ifosfamide: The potential of NMR in stability studies.

Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis.

Retrospective analysis of second-line chemotherapy outcomes with paclitaxel or docetaxel in correlation with STMN1 polymorphism in advanced non-small cell lung cancer patients.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

How does on-demand delivery impact the accessibility and equity of community pharmacies? Perspective from groups with heterogeneous geographic-digital barriers.

Sustaining Health Promotion in Australian Supermarkets: Qualitative Perspectives From the Reach for the Stars Programme.

A descriptive analysis for the markets for counterfeit products.

Do not smile when acquiring consumer selfies for multi-attribute skin profiling and baseline deep learning evaluation.

E-cigarette concept flavors in the United States: An analysis of product packages from online stores.

Misalignment between ultra-processed status and 'better for you' claims on premix alcohol products.

Related Experiment Videos

Commercialisation of disease management

Related Concept Videos

Related Articles